Sigma Foods (SIGMAF) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
13 Nov, 2025Executive summary
Completed transformation to a pure-play packaged/branded food business, finalizing the Alpek spin-off and reclassifying as Consumer Staples under GICS as of April 2025.
Achieved record quarterly revenues in 2Q25, with strong operating momentum and positive share price revaluation.
Corporate rebranding and ticker change preparations are underway, with an extraordinary shareholders meeting planned.
Financial highlights
2Q25 revenues reached US$2.297 billion, up 1% year-over-year; currency-neutral growth was 7%.
2Q25 EBITDA was US$305 million, including up to US$77 million in non-recurring insurance gains; comparable EBITDA was US$246 million, down 10% year-over-year.
Year-to-date EBITDA reached US$576 million, up 10% year-over-year, benefiting from US$110 million in non-recurring items.
U.S. achieved record quarterly volume and revenues, with EBITDA up 1% year-over-year.
Europe’s EBITDA included a non-recurring gain of EUR 68 million from insurance reimbursements for flood damages.
Outlook and guidance
Year-to-date comparable EBITDA is on track with full-year guidance despite higher-than-expected protein input costs.
Focus remains on sustaining positive trends into the second half of 2025, with expectations for stronger margins in Mexico if FX remains favorable.
Europe expected to see margin improvement in 2026 and normalized margins of 7-8% by 2027 as new plant projects are completed.
Strategic focus on executing rebranding, engaging investors, and delivering on financial commitments.
Latest events from Sigma Foods
- Record 4Q25 EBITDA, strong innovation, and sustainability progress drive growth outlook.SIGMAF
Corporate presentation25 Feb 2026 - Record 2025 results and Alpek spin-off set up strong 2026 growth and higher dividends.SIGMAF
Q4 202512 Feb 2026 - EBITDA and guidance rose on Sigma's record results, with debt reduction and transformation progressing.SIGMAF
Q2 20242 Feb 2026 - Sigma posts record EBITDA as ALFA advances Alpek spin-off and targets lower leverage.SIGMAF
Q3 202418 Jan 2026 - Record results and transformation position for growth as Alpek spin-off nears completion.SIGMAF
Q4 202419 Dec 2025 - Record revenues and sequential EBITDA gains despite cost and operational headwinds.SIGMAF
Q3 202514 Dec 2025 - Transformation complete, 1Q25 EBITDA at US$220M, S&P upgrades to 'BBB'.SIGMAF
Q1 202529 Nov 2025